Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-resistant tuberculosis in pediatrics

D S Swanson1, J R Starke

  • 1Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

Pediatric Clinics of North America
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical standards for drug-susceptible TB in children and adolescents.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Administration and monitoring of clofazimine for NTM infections in children with and without cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2021
Same author

Epidemiology and clinical characteristics of childhood TB identified using active and passive case finding.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021
Same author

Global shortages of BCG vaccine and tuberculous meningitis in children.

The Lancet. Global health·2018
Same author

Controversies in tuberculous infection among pediatric infectious disease specialists in North America.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2016
Same author

Safety and completion of a 4-month course of rifampicin for latent tuberculous infection in children.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2014
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Drug-resistant tuberculosis cases are rising in the US. Understanding resistance mechanisms and improving public health measures are key to preventing its spread and ensuring effective treatment.

Area of Science:

  • Microbiology
  • Public Health
  • Genetics

Background:

  • Tuberculosis (TB) incidence in the US has increased over the last decade.
  • A concurrent dramatic rise in drug-resistant tuberculosis cases is observed.
  • Drug resistance poses significant challenges to effective TB control.

Purpose of the Study:

  • To investigate the genetic mechanisms underlying drug resistance in tuberculosis.
  • To inform the development of improved diagnostic and therapeutic strategies for drug-resistant TB.
  • To highlight the importance of public health interventions in preventing the spread of resistant strains.

Main Methods:

  • Ongoing research into the genetic basis of drug resistance.
  • Analysis of current treatment regimens for drug-resistant tuberculosis.

Related Experiment Videos

  • Evaluation of public health measures for TB control.

    • Main Results:

    • Genetic mechanisms of resistance are being elucidated.
    • Treatment for drug-resistant TB is complex, lengthy (9-18 months), and involves multiple toxic drugs.
    • Drug resistance is currently localized and preventable with appropriate public health actions.

    Conclusions:

    • Understanding resistance genetics can lead to better diagnostics and treatments.
    • Adherence to treatment regimens and robust public health strategies are crucial.
    • Preventing further emergence of drug-resistant tuberculosis requires focused attention on current control measures.